120 related articles for article (PubMed ID: 6304745)
1. Beneficial actions of nalorphine during hemorrhagic shock in cats.
Hock CE; Curtis MT; Jaffe JS; Lefer AM
Proc Soc Exp Biol Med; 1983 May; 173(1):76-81. PubMed ID: 6304745
[TBL] [Abstract][Full Text] [Related]
2. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
Curtis MT; Lefer AM
Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
Curtis MT; Lefer AM
Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
[TBL] [Abstract][Full Text] [Related]
4. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
Hock CE; Su JY; Lefer AM
Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
[TBL] [Abstract][Full Text] [Related]
5. Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock.
Curtis MT; Lefer AM
Eur J Pharmacol; 1982 Mar; 78(3):307-13. PubMed ID: 6279411
[TBL] [Abstract][Full Text] [Related]
6. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
Hock CE; Su JY; Lefer AM
Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
[TBL] [Abstract][Full Text] [Related]
7. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
Bitterman H; Yanagisawa A; Lefer AM
Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of anisodamine in hemorrhagic shock.
Su J; Hock CE; Lefer AM
Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II receptor blockade by [Sar1-Ala8]angiotensin II in hemorrhagic shock.
Trachte GJ; Lefer AM
Am J Physiol; 1979 Feb; 236(2):H280-5. PubMed ID: 311160
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
Flynn JT; Lefer AM
Circ Res; 1977 Apr; 40(4):422-8. PubMed ID: 844155
[TBL] [Abstract][Full Text] [Related]
11. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
Stahl GL; Bitterman H; Terashita Z; Lefer AM
Eur J Pharmacol; 1988 May; 149(3):233-40. PubMed ID: 3409951
[TBL] [Abstract][Full Text] [Related]
12. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
Bitterman H; Smith BA; Lefer AM
Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
[TBL] [Abstract][Full Text] [Related]
13. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
Freeman JG; Hock CE; Edmonds JS; Lefer AM
J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
[TBL] [Abstract][Full Text] [Related]
14. Protective actions of naloxone in hemorrhagic shock.
Curtis MT; Lefer AM
Am J Physiol; 1980 Sep; 239(3):H416-21. PubMed ID: 7435587
[TBL] [Abstract][Full Text] [Related]
15. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
Bitterman H; Smith BA; Lefer DJ; Lefer AM
J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
[TBL] [Abstract][Full Text] [Related]
16. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
Trachte GJ; Lefer AM
Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock.
Patel JP; Beck LD; Briglia FA; Hock CE
Crit Care Med; 1995 Feb; 23(2):231-7. PubMed ID: 7867347
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
Bitterman H; Phillips GR; Dragon G; Lefer AM
J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
Bitterman H; Lefer DJ; Lefer AM
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
[TBL] [Abstract][Full Text] [Related]
20. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
Bitterman H; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
